Literature DB >> 20583921

T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species.

Yira Rosalba Díaz1, Ricardo Rojas, Liliana Valderrama, Nancy Gore Saravia.   

Abstract

BACKGROUND: T cell differentiation determines susceptibility and resistance to experimental cutaneous leishmaniasis, yet mixed T1/Th2 responses characterize the clinical spectrum of human infection with Leishmania (Viannia) species.
MATERIALS AND METHODS: To discern the interrelationship of T cell differentiation and outcome of human infection, we examined factors that regulate T cell differentiation and Th1/Th2 cytokine responses in asymptomatic infection, active and historical chronic and recurrent cutaneous leishmaniasis. T-bet, GATA-3, Foxp3, and cytokine gene expression were quantified by real-time polymerase chain reaction and correlated with interleukin 2, interferon gamma, tumor necrosis factor alpha, interleukin 4, interleukin 13, and interleukin 10 secretion during in vitro response to live Leishmania panamensis.
RESULTS: Higher GATA-3 expression than T-bet expression occurred throughout the 15 days of coculture with promastigotes; however, neither transcription nor secretion of interleukin 4 was detected. A sustained inverse correlation between GATA-3 expression and secretion of proinflammatory cytokines interferon gamma and tumor necrosis factor alpha was observed in asymptomatic infection. In contrast, higher T-bet expression and a higher ratio of T-bet to GATA-3 characterized active recurrent disease. Down-regulation of T-bet and GATA-3 expression and increased interleukin 2 secretion, compared with control subjects, was directly correlated with Foxp3 expression and interleukin 13 secretion in chronic disease.
CONCLUSIONS: Regulation of the inflammatory response rather than biased Th1/Th2 response distinguished asymptomatic and recalcitrant outcomes of infection with Leishmnania viannia species.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583921      PMCID: PMC4850829          DOI: 10.1086/653829

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

Review 1.  Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights.

Authors:  Davide Agnello; Carla S R Lankford; Jay Bream; Akio Morinobu; Massimo Gadina; John J O'Shea; David M Frucht
Journal:  J Clin Immunol       Date:  2003-05       Impact factor: 8.317

Review 2.  Persistent infections by Leishmania (Viannia) braziliensis.

Authors:  J L Ramírez; P Guevara
Journal:  Mem Inst Oswaldo Cruz       Date:  1997 May-Jun       Impact factor: 2.743

3.  Interleukin-13 gene expression is regulated by GATA-3 in T cells: role of a critical association of a GATA and two GATG motifs.

Authors:  Cecile Lavenu-Bombled; Cecelia D Trainor; Iman Makeh; Paul-Henri Romeo; Isabelle Max-Audit
Journal:  J Biol Chem       Date:  2002-03-13       Impact factor: 5.157

4.  Cell mediated immunity in American cutaneous and mucosal leishmaniasis.

Authors:  E M Carvalho; W D Johnson; E Barreto; P D Marsden; J L Costa; S Reed; H Rocha
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

5.  Epidemiology of cutaneous leishmaniasis in Colombia: a longitudinal study of the natural history, prevalence, and incidence of infection and clinical manifestations.

Authors:  K A Weigle; C Santrich; F Martinez; L Valderrama; N G Saravia
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

6.  Cytokine patterns in the pathogenesis of human leishmaniasis.

Authors:  C Pirmez; M Yamamura; K Uyemura; M Paes-Oliveira; F Conceição-Silva; R L Modlin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 7.  Interleukin-4 and interleukin-13: their similarities and discrepancies.

Authors:  P Chomarat; J Banchereau
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

8.  An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3.

Authors:  J D Farrar; W Ouyang; M Löhning; M Assenmacher; A Radbruch; O Kanagawa; K M Murphy
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

9.  GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.

Authors:  Pierre-Yves Mantel; Harmjan Kuipers; Onur Boyman; Claudio Rhyner; Nadia Ouaked; Beate Rückert; Christian Karagiannidis; Bart N Lambrecht; Rudolf W Hendriks; Reto Crameri; Cezmi A Akdis; Kurt Blaser; Carsten B Schmidt-Weber
Journal:  PLoS Biol       Date:  2007-12       Impact factor: 8.029

10.  CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis.

Authors:  Charles F Anderson; Mohammed Oukka; Vijay J Kuchroo; David Sacks
Journal:  J Exp Med       Date:  2007-02-05       Impact factor: 14.307

View more
  23 in total

1.  Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis.

Authors:  Carolina Gallego; Douglas Golenbock; Maria Adelaida Gomez; Nancy Gore Saravia
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Chronicity of dermal leishmaniasis caused by Leishmania panamensis is associated with parasite-mediated induction of chemokine gene expression.

Authors:  Adriana Navas; Deninson Alejandro Vargas; Marina Freudzon; Diane McMahon-Pratt; Nancy Gore Saravia; María Adelaida Gómez
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

Review 3.  The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.

Authors:  Mary-Anne Hartley; Stefan Drexler; Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Trends Parasitol       Date:  2014-06-20

4.  Profiles of Local and Systemic Inflammation in the Outcome of Treatment of Human Cutaneous Leishmaniasis Caused by Leishmania (Viannia).

Authors:  Adriana Navas; Olga Fernández; Carolina Gallego-Marín; María Del Mar Castro; Mariana Rosales-Chilama; Julieth Murillo; Alexandra Cossio; Diane McMahon-Pratt; Nancy Gore Saravia; María Adelaida Gómez
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

5.  Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans.

Authors:  Shikha Arora; Michal A Olszewski; Tiffany M Tsang; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2011-03-07       Impact factor: 3.441

6.  Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.

Authors:  Tiago M Castilho; Karen Goldsmith-Pestana; Caterin Lozano; Liliana Valderrama; Nancy G Saravia; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

7.  Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.

Authors:  Qian-Qian Chen; Li Yan; Chang-Zheng Wang; Wei-Hua Wang; Hui Shi; Bin-Bin Su; Qing-Huan Zeng; Hai-Tao Du; Jun Wan
Journal:  World J Gastroenterol       Date:  2013-08-07       Impact factor: 5.742

8.  Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival.

Authors:  Maria Adelaida Gómez; Adriana Navas; Ricardo Márquez; Laura Jimena Rojas; Deninson Alejandro Vargas; Victor Manuel Blanco; Roni Koren; Dan Zilberstein; Nancy Gore Saravia
Journal:  J Antimicrob Chemother       Date:  2013-08-24       Impact factor: 5.790

Review 9.  The evolving role of T-bet in resistance to infection.

Authors:  Gretchen Harms Pritchard; Ross M Kedl; Christopher A Hunter
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

10.  Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response.

Authors:  Carolina Ramírez; Yira Díaz-Toro; Jair Tellez; Tiago M Castilho; Ricardo Rojas; Nicholas A Ettinger; Irina Tikhonova; Neal D Alexander; Liliana Valderrama; Janet Hager; Mary E Wilson; Aiping Lin; Hongyu Zhao; Nancy G Saravia; Diane McMahon-Pratt
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.